Cannabis
MindBio Therapeutics, IMIO Life to take the stage at the LSD Conference: A Molecular Masterclass
Toronto, Ontario–(Newsfile Corp. – February 16, 2022) – Microdose Psychedelic Insights (“Microdose”) the leading guide to the business of psychedelics will be hosting the upcoming LSD Conference in an entirely virtual format which will be held on February 17 starting at 1:15pm EST.
Headline sponsor of the event is MindBio Therapeutics a clinical stage drug development company conducting research into microdosing and medicinal use of psychedelic medicines to treat a range of debilitating mental health conditions.
The event is brought to you by IMIO. IMIO is dedicated to identifying and refining the use of psychedelic molecules to better treat chronic pain. The approach is to combine known molecules with our proprietary BTLS drug delivery technology, enabling better penetration of molecules into the brain, reducing the therapeutic dose, providing a safer treatment while minimizing adverse effects.
Explore the Schedule
*All times are Eastern Standard Time Zone.
1:15pm: Emerging Treatments in Mental Health – MindBio Therapeutics
Featuring Justin Hanka.
1:30 pm: The History of That “Curious Molecule”
Featuring Crystal Carson, William Leonard Pickard.
2:00pm: LSD Assisted Therapies/Retreats in Germany
Featuring Maja Theresa Balz, Konstantin Neumann.
2:30pm: Overcoming the Lingering Effects of Lysergic Acid Diethylamide – IMIO Life
Featuring Dr. Tal Hasson.
3:00pm: LSD IP: Tripping Over the Patent Landscape?
Featuring Graham Pechenik.
3:30pm: Psychotherapy With a Side of LSD: The Neuroscience and Where it’s Headed
Featuring Najla Guthrie.
Additional information about the LSD Masterclass, as well as details for registration, can be found at the following link: microdose.buzz/lsd-masterclass.
### Ends ###
NOTES TO EDITORS:
About Microdose Psychedelic Insights
Microdose Psychedelic Insights aims to unlock the potential of psychedelic medicine through Industry events, market intelligence, original, evidence-based content, strategy, and community. We enable and empower society at large to make better, more mindful decisions about psychedelics and their intersection with healthcare, medicine, and personal growth. We work with the industry’s most influential stakeholders, some of the world’s best-known brands, and an unrivalled network of scientists, researchers, analysts, innovators, investors, and advisors.
About Molecular Masterclass Conference Series
The Molecular Masterclass is a speaker series designed for deep dives into the world’s favourite psychoactive and psychedelic substances.
Previous events included: The Ketamine Conference, The Ibogaine Conference, The Mushroom Conference, and The MDMA Conference.
Additional information about LSD Masterclass, including registration details, speakers are available at https://microdose.buzz/lsd-conference.
Events Contact: [email protected]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/113978
-
Cannabis1 week ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Cannabis1 week ago
IM Cannabis Reports First Quarter Financial Results
-
Innocan1 week ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis5 days ago
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
-
Cannabis5 days ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis4 days ago
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth
-
Cannabis3 days ago
Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032
-
Cannabis3 days ago
Rubicon Organics Reports Q1 2024 Financial Results